Brii Biosciences Limited Stock Today
| BRIBF Stock | USD 0.13 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 23
|
Brii Biosciences is trading at 0.13 as of the 3rd of December 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.13. Brii Biosciences has about a 23 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Brii Biosciences Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of November 2024 and ending today, the 3rd of December 2024. Click here to learn more.
Brii Biosciences Limited engages in the development of medicines for the treatment of infectious and central nervous system diseases. The company was incorporated in 2017 and is based in Beijing, China. Brii Bioscience is traded on OTC Exchange in the United States. The company has 723.35 M outstanding shares. More on Brii Biosciences Limited
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Brii Pink Sheet Highlights
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Brii Biosciences Limited [BRIBF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Small-Cap' category with a current market capitalization of 941.75 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Brii Biosciences's market, we take the total number of its shares issued and multiply it by Brii Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Brii Biosciences classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 723.35 M outstanding shares.
Brii Biosciences Limited has accumulated about 3.22 B in cash with (879.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Brii Biosciences Probability Of Bankruptcy
Ownership AllocationBrii Biosciences holds a total of 723.35 Million outstanding shares. Over half of Brii Biosciences' outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Brii Ownership Details
Brii Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Brii Biosciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
| All Next | Launch Module |
Brii Biosciences Corporate Management
| Lianhong Xu | Head Discovery | Profile | |
| Zhi Hong | Ex Cofounder | Profile | |
| CFA JD | Company Officer | Profile | |
| Karen Neuendorff | Chief HR | Profile | |
| Li MD | Chief Officer | Profile | |
| Qing Zhu | Head RD | Profile | |
| Coy Stout | Head Advocacy | Profile |
Other Information on Investing in Brii Pink Sheet
Brii Biosciences financial ratios help investors to determine whether Brii Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Brii with respect to the benefits of owning Brii Biosciences security.